Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?

Myocardial Revascularization SurgeryThe use of both internal thoracic (mammary) arteries for myocardial revascularization surgery might improve long-term outcomes, compared with the use of a single internal thoracic artery.

 

Patients scheduled for myocardial revascularization surgery (only multivessel procedures; combined valve procedures were excluded) were randomized to receive a single internal-thoracic-artery graft (internal thoracic artery for the anterior descending artery, other vessels with grafts from veins or the radial artery) or two internal-thoracic-artery grafts (other vessels with grafts from veins or the radial artery) in 28 cardiac surgical centers in 7 countries.

 

The primary endpoint was all-cause death at 10 years, and the secondary endpoint was a composite of all-cause death, acute myocardial infarction, or stroke. An interim analysis was prespecified at 5 years of follow-up and is reported in this summary.

 

A total of 3102 patients were enrolled; 1554 were randomized to receive a single internal-thoracic-artery graft and 1548 to receive a double internal-thoracic-artery graft.

 

At 5 years of follow-up, the mortality rate was 8.7% for patients in the double internal-thoracic-artery graft group and 8.4% for those in the single internal-thoracic-artery graft group (hazard ratio [HR]: 1.04; 95% confidence interval [CI]: 0.81 to 1.32; p = 0.77). The rate of the composite endpoint of all-cause death, infarction, and stroke was 12.2% vs. 12.7%, respectively (HR: 0.96; 95% CI: 0.79 to 1.17; p = 0.69).

 

Differences were indeed observed regarding the risk of sternal wound infection, which was higher among those receiving a double internal-thoracic-artery graft (3.5% vs. 1.9%; p = 0.005), and the need for sternal reconstruction (1.9% vs. 0.6%; p = 0.002).

 

Conclusion

Among patients undergoing myocardial revascularization surgery, there were no benefits at 5 years for those receiving double internal-thoracic-artery grafts when compared with those in which only the left internal thoracic artery was used. Sternal wound infections and the need for sternal reconstruction were significantly more frequent in patients receiving double internal-thoracic-artery grafts. Ten-year follow-up is ongoing, and benefits are yet to be seen.

 

Original title: Randomized Trial of Bilateral Versus Single Internal-Thoracic-Artery Grafts.

Reference: David P. Taggart et al. N Engl J Med. 2016 Nov 14. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...